ImmuCell Corporation Increase (Decrease) in Other Operating Assets
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Other Operating Assets of -$6.03 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-13
- ImmuCell Corporation increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$2.50K, a 130.43% decline year-over-year.
- ImmuCell Corporation increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$3.53K, a 129.31% decline year-over-year.
- ImmuCell Corporation increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$6.66K, a 249.00% decline year-over-year.
- ImmuCell Corporation increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$9.27K.
- ImmuCell Corporation increase (decrease) in other operating assets for fiscal 2025 was $4.32K.
- ImmuCell Corporation increase (decrease) in other operating assets for fiscal 2024 was -$24.29K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.03K 10-Q · filed 2026-08-13 | -$12.69K derived: sum of 3 quarters · filed 2026-08-13 | -$21.96K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$3.53K 10-Q · filed 2026-05-14 | -$10.19K derived: sum of 2 quarters · filed 2026-05-14 | -$19.46K derived: sum of 3 quarters · filed 2026-05-14 | -$11.26K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$6.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$15.93K derived: sum of 2 quarters · filed 2026-03-30 | -$7.73K derived: sum of 3 quarters · filed 2026-08-13 | $4.32K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$9.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.07K derived: sum of 2 quarters · filed 2026-08-13 | $10.98K 10-Q · filed 2025-11-13 | $15.45K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $8.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $20.25K 10-Q · filed 2026-08-13 | $24.72K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | $12.05K 10-Q · filed 2026-05-14 | $16.52K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $4.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$24.29K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | -$28.76K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |